Liquid Biopsy Technique Tracks Tumor Burden and Subtypes in Small-Cell Lung
6 Articles
6 Articles
Israeli and American scientists have developed a blood test that could make the monitoring and future treatment of small cell lung cancer more accurate. The technology shows not only how big the tumor is, but also which genes are active in the cancer cells. The study was led by Prof. Nir Friedman and Dr. Gavriel Fialkov of the Hebrew University and Hadassah Medical School, along with Dr. Nobuyuki Takahashi and Dr. Anish Thomas of the US National…
Agency AJN.- An international team, led by researchers from the Weizmann Institute of Sciences and the Hebrew University of Jerusalem, developed an experimental blood test that detects breast cancer in its early stages with an accuracy of 95% in the case of localized tumors of less than two centimeters. The test also [...] The entry An Israeli blood test detects breast cancer in its early stages with an accuracy of 95% appears first on AJN News …
A new blood test method published in the journal Nature represents a major breakthrough in medicine, capable of accurately identifying early-stage breast cancer and warning of recurrence risks after treatment. Artificial intelligence is being applied to interpreting breast cancer scan results. Multimodal approaches are being used to manage breast cancer in the era of precision medicine. Israel is developing an AI model to predict the effectivene…
An international team, led by researchers from the Weizmann Institute of Science and the Hebrew University of Jerusalem, has developed an experimental blood test that detects breast cancer at an early stage, with 95% accuracy - ΙΝΑΦΤΕΜΟΠΟΡΙΚΙ
Researchers have developed a technique that identifies subtypes of small cell lung cancer and monitors the disease through blood tests, eliminating invasive biopsies. Read more in the Paraná Tribune.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
